Effects of chronic nicotine treatment and withdrawal on hypothalamic proopiomelanocortin gene expression and neuroendocrine regulation

Psychoneuroendocrinology

Volumn 23, Issue 3, 1998, Pages 245-259

  Rasmussen, Dennis D ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Endorphins; Hypothalamus; mRNA; Nicotine; Proopiomelanocortin; Withdrawal

Indexed keywords

ENDORPHIN; MESSENGER RNA; NICOTINE; PROOPIOMELANOCORTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DRUG EFFECT; DRUG WITHDRAWAL; GENE EXPRESSION REGULATION; HORMONAL REGULATION; LIGHT DARK CYCLE; NEUROENDOCRINE SYSTEM; NEUROMODULATION; NEUROTRANSMITTER RELEASE; NONHUMAN; PERIKARYON; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; TUBEROHYPOPHYSEAL TRACT;

ANIMALS; BETA-ENDORPHIN; BRAIN MAPPING; GENE EXPRESSION; HYPOTHALAMUS; MALE; NEUROSECRETORY SYSTEMS; NICOTINE; PRO-OPIOMELANOCORTIN; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS;

EID: 0031826746     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(98)00003-1     Document Type: Article

References (69)

1. Aceto, M. D., Scates, S. M., Ji, Z. and Bowman, E. R. (1993) Nicotine's opioid and anti-opioid interactions: proposed role in smoking behavior. European Journal of Pharmacology 248, 333-335.
2. Amalric, M., Cline, E. J., Martinez, J. L., Jr, Bloom, F. E. and Koob, G. F. (1987) Rewarding properties of β-endorphin as measured by conditioned place preference. Psychopharmacology 91, 14-19.
3. Andersson, K., Fuxe, K., Eneroth, P., Mascagni, F. and Agnati, L. F. (1985) Effects of acute intermittent exposure to cigarette smoke on catecholamine levels and turnover in various types of hypothalamic DA and NA nerve terminal systems as well as on the secretion of adenohypophyseal hormones and cortisone. Acta Physiologica Scandinavica 124, 277-285.
4. Baron, J. A., Comi, R. J., Cryns, V., Brinckjohnsen, T. and Mercer, N. G. (1995) The effect of cigarette smoking on adrenal cortical hormones. Journal of Pharmacology and Experimental Therapeutics 272, 151-155.
5. Beaulieu, S., Gagne, B. and Barden, N. (1988) Glucocorticoid regulation of proopiomelanocortin messenger ribonucleic acid content of rat hypothalamus. Molecular Endocrinology 2, 727-731.
6. Blumberg, H. H., Cohen, S. D., Dronfield, B. E., Mordecai, E. A., Roberts, C. J. and Hawks, D. (1974) British opiate users: I. People approaching London drug treatment centres. International Journal of Addiction 1, 1-23.
7. Boyadjieva, N. I. and Sarkar, D. K. (1997) The secretory response of hypothalamic β-endorphin neurons to acute and chronic nicotine treatments and following nicotine withdrawal. Life Science 61, 59-66.
8. Brase, D. A., Tseng, L. F., Loh, H. H. and Way, E. L. (1974) Cholinergic modification of naloxone-induced jumping in morphine dependent mice. European Journal of Pharmacology 26, 1-8.
9. Briggs, W. J. (1973) Cigarette smoking and infertility in men. Medical Journal of Australia 1, 616-617.
10. Caggiula, A. R., Epstein, L. H., Antelman, S. M., Saylor, S., Knopf, S., Perkins, K. A. and Stiller, R. (1993) Acute stress or corticosterone administration reduces responsiveness to nicotine: implications for a mechanism of conditioned tolerance. Psychopharmacology 111, 499-507.
11. Caggiula, A. R., Epstein, L. H., Antelman, S. M., Saylor, S. S., Perkins, K. A., Knopf, S. and Stiller, R. (1991) Conditioned tolerance to the anorectic and corticosterone-elevating effects of nicotine. Pharmacology Biochemistry and Behaviour 40, 53-59.
12. Collins, A. C. and Marks, M. J. (1996) Are nicotinic receptors activated or inhibited following chronic nicotine treatment? Drug Development and Research 38, 231-242.
13. Comb, M., Hyman, S. E. and Goodman, H. M. (1987) Mechanisms of trans-synaptic regulation of gene expression. Trends in Neuroscience 10, 473-478.
14. Cryer, P. E., Haymond, M. W., Santiago, J. V. and Shah, S. D. (1976) Norepinephrine and epinephrine release and the adrenergic mediation of smoking-associated hemodynamics and metabolic events. New England Journal of Medicine 295, 573-577.
15. Davenport, K. E., Houdi, A. A. and Van Loon, G. R. (1990) Nicotine protects against m-opioid receptor antagonism by β-funaltrexamine: evidence for nicotine-induced release of endogenous opioids in brain. Neuroscience Letters 113, 40-46.
16. Deyo, S. N., Swift, R. M. and Miller, R. J. (1979) Morphine and endorphins modulate dopamine turnover in rat median eminence. Proceedings of the National Academy of Science USA 76, 3006-3009.
17. Everitt, B. J., Meister, B., Hökfelt, T., Melander, T., Terenius, L., Rökaeus, A., Theodorsson-Norheim, E., Dockray, G., Edwardson, J., Cuello, C., Eide, R., Goldstein, M., Hemmings, H., Ouimet, C., Walaas, I., Greengard, P., Vale, W., Weber, E., Wu, J. -Y. and Chang, K. -J. (1986) The hypothalamic arcuate nucleus-median eminence complex: immunocytochemistry of transmitters, peptides and DARPP-32 with special reference to coexistence in dopamine neurons. Brain Research Reviews 11, 97-155.
18. Field, A. E., Colditz, G. A., Willet, W. C., Longcope, C. and McKinlay, J. B. (1994) The relation of smoking, age, relative weight, and dietary intake to serum adrenal steroids, sex hormones, and sex hormone-binding globulin in middle-aged men. Journal of Clinical Endocrinology and Metabolism 79(5), 1310-1316 (abstract).
19. Fuxe, K., Andersson, K., Eneroth, P., Harfstrand, A. and Agnati, L. F. (1989) Neuroendocrine actions of nicotine and of exposure to cigarette smoke: medical implications. Psychoneuroen-docrinology 14, 19-41.
20. Genazzani, A. R., De Ramundo, B. M., Criscuolo, M., De Gaetani, C., Ficarra, G., Genazzani, A. D., Petraglia, F. and Trentini, G. P. (1990) Acetyl-1-carnitine restores the daily pattern of hypothalamic β-endorphin in rats exposed to continuous light. European Journal of Pharmacology 186, 177-180.
21. Gianutsos, G., Drawbaugh, R., Hynes, M. and Lal, H. (1975) The narcotic withdrawal syndrome in the rat. In: Ehrenpreis, S. and Neidle, A. (Eds.), Methods In Narcotic Research. Dekker, New York, pp. 293-309.
22. Glassman, A. H., Jackson, W. K., Walsh, B. T. and Roose, S. P. (1984) Cigarette craving, smoking withdrawal, and clonidine. Science 226, 864-866.
23. Gorelick, D. A., Rose, J. and Jarvik, M. E. (1989) Effect of naloxone on cigarette smoking. Journal of Substance Abuse 1, 153-159.
24. Gossop, M., Powell, J., Grey, S. and Hajek, P. (1990) What do opiate addicts and cigarette smokers mean by 'craving'? A pilot study. Drug and Alcohol Dependency 26, 85-87.
25. Grun, E. A., Pauly, J. R. and Collins, A. C. (1992) Adrenalectomy reverses chronic injection-induced tolerance to nicotine. Psychopharmacology 109, 299-304.
26. Gudehithlu, K. P., Hubble, J. P., Hadjiconstantinou, M. and Tejwani, G. A. (1989) Nicotine alters opioid peptide levels in striatum and hypothalamus of mouse brain. Proceedings of the Society of Neuroscience Management 15, 146 (abstract).
27. Hodson, C. A., Davenport, A., Price, G. and Burden, H. W. (1993) Naltrexone treatment attenuates the inhibitory effect of nicotine treatment on serum LH in rats. Life Science 53, 839-846.
28. Hökfelt, B. (1961) The effect of smoking on the production of adrenocorticoid hormones. Acta Medica Scandinavica (supplement) 369, 123-124.
29. Jakubowski, M. and Roberts, J. L. (1992) Multiplex solution hybridization-RNase protection assay for quantitation of different RNA transcripts from snap-frozen neuroendocrine tissues of individual animals. Journal of Neuroendocrinology 4, 79-89.
30. Jones, V. C., Tomlin, S., Rees, L. H., McLoughlin, L., Besser, G. M. and Wen, H. L. (1980) Increased β-endorphin but not met-enkephalin levels in human cerebrospinal fluid after acupuncture for recurrent pain. Lancet 946-948.
31. Karras, A. and Kane, J. M. (1980) Naloxone reduces cigarette smoking. Life Science 27, 1541-1545.
32. Khosla, T. and Lowe, C. R. (1971) Obesity and smoking habits. British Medical Journal 1, 880-881.
33. Kubo, T., Amano, H., Kurahashi, K. and Misu, Y. (1989) Nicotine-induced regional changes in brain noradrenaline and dopamine turnover in rats. Journal of Pharmacobiodynamics 12, 107-112.
34. Leong, D. A., Frawley, L. S. and Neill, J. D. (1983) Neuroendocrine control of prolactin secretion. Annual Review of Physiology 45, 109-127.
35. Malin, D. H., Lake, J. R., Carter, V. A., Cunningham, J. S. and Wilson, O. B. (1993) Naloxone precipitates nicotine abstinence syndrome in the rat. Psychopharmacology 112, 339-342.
36. Malin, D. H., Lake, J. R., Newlin-Maultsby, P., Roberts, L. K., Lanier, J. G., Carter, V. A., Cunningham, J. S. and Wilson, O. B. (1992) Rodent model of nicotine abstinence syndrome. Pharmacology Biochemistry and Behaviour 43, 779-784.
37. Malin, D. H., Lake, J. R., Payne, M. C., Short, P. E., Carter, V. A., Cunningham, J. S. and Wilson, O. W. (1996) Nicotine alleviation of nicotine abstinence syndrome is naloxone-reversible. Pharmacology Biochemistry and Behaviour 53, 81-85.
38. Malizia, E., Andreucci, G., Cerbo, R. and Colombo, G. (1978) Effect of naloxone on acupunctureelicited analgesia in addicts. Advances in Biochemistry and Psychopharmacology 18, 361-362.
39. Matera, C. and Wardlaw, S. L. (1993) Dopamine and sex steroid regulation of POMC gene expression in the hypothalamus. Neuroendocrinology 58, 493-500.
40. Morley, J. E. (1989) Appetite regulation: The role of peptides and hormones. Journal of Endocrinological Investigation 12, 135-147.
41. Nisell, M., Nomikos, G. G. and Svensson, T. H. (1994) Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area. Synapse 16, 36-44.
42. O'Donohue, T. L. and Dorsa, D. M. (1982) The opiomelanotropinergic neuronal and endocrine systems. Peptides 3, 353-395.
43. Palmer, R. F. and Berens, A. (1983) Double blind study of the effects of naloxone on the pleasure of cigarette smoking. Federation Proceedings 42, 654 (abstract).
44. Pastorcic, M., Boyadjieva, N. and Sarkar, D. K. (1994) Comparison of the effects of alcohol and acetaldehyde on proopiomelanocortin mRNA levels and beta-endorphin secretion from hypothalamic neurons in primary cultures. Molecular and Cellular Neuroscience 5, 580-586.
45. Patchev, V. K., Racke, K. and Almeida, O. F. X. (1991) Adrenalectomy and experimental hypercorticalism modulate the basal, corticotropin-releasing-hormone- and arginine-vasopressin-stimulated release of hypothalamic beta-endorphin. Neuroendocrinology 54, 111-117.
46. Pauly, J. R., Grun, E. U. and Collins, A. C. (1992a) Glucocorticoid regulation of sensitivity to nicotine. In: Lippiello, P. M., Collins, A. C., Gray, J. A. and Robinson, J. H. (Eds.), The Biology of Nicotine. Raven Press, New York, pp. 121-137.
47. Pauly, J. R., Grun, E. U. and Collins, A. C. (1992b) Tolerance to nicotine following chronic treatment by injections: A potential role for corticosterone. Psychopharmacology (Berlin) 108, 33-39.
48. Pechnick, R. N. (1993) Effects of opioids on the hypothalamo-pituitary-adrenal axis. Annual Review of Pharmacology and Toxicology 33, 353-382.
49. Pomerleau, O. F. and Rosecrans, J. (1989) Neuroregulatory effects of nicotine. Psychoneuroendocrinology 14, 407-423.
50. Puddey, I. B., Vandongen, R., Beilin, L. J. and English, D. (1976) Haemodynamic and neuroendocrine consequences of stopping smoking-a controlled study. Clinical and Experimental Pharmacology and Physiology 11, 423-426.
51. Rasmussen, D. D. (1991) The interaction between mediobasohypothalamic dopaminergic and endorphinergic neuronal systems as a key regulator of reproduction: an hypothesis. Journal of Endocrinological Investigation 14, 323-352.
52. Rasmussen, D. D. (1995) Nicotine effects on the neuroendocrine regulation of reproduction. In: Sarkar, D. K., Barnes, C. D. (Eds.), The Reproductive Neuroendocrinology of Aging and Drug Abuse, CRC Press, Boca Raton, FL, pp. 243-270.
53. Rasmussen, D. D., Jakubowski, M., Allen, D. L. and Roberts, J. L. (1992) Positive correlation between proopiomelanocortin and tyrosine hydroxylase mRNA levels in the mediobasohypothalamus of ovariectomized rats: response to estradiol replacement and withdrawal. Neuroendocrinology 56, 285-294.
54. Reisine, T. D., Mezey, E., Palkovits, M., Heisler, S. and Axelrod, J. (1984) Beta adrenergic control of adrenocorticotropic hormone release from the anterior pituitary. In: Usdin, E., Carlsson, A., Dahlstrom, A., Engel, J. (Eds.), Catecholamines: Neuropharmacology and Central Nervous System Theoretical Aspects, Alan R. Liss, New York, pp. 419-423.
55. Rosecrans, J. A., Hendry, J. S. and Hong, J. -S. (1985) Biphasic effects of chronic nicotine treatment on hypothalamic immunoreactive β-endorphin in the mouse. Pharmacology Biochemistry and Behaviour 23, 141-143.
56. Shieh, K. -R. and Pan, J. -T. (1997) Nicotinic control of tuberoinfundibular dopaminergic neuron activity and prolactin secretion: diurnal rhythm and involvement of endogenous opioidergic system. Brain Research 756, 266-272.
57. Shoaib, M. and Shippenberg, T. S. (1996) Adrenalectomy attenuates nicotine-induced dopamine release and locomotor activity in rats. Psychopharmacology 128, 343-350.
58. Spanagel, R., Herz, A., Bals-Kubik, R. and Shippenberg, T. S. (1991) β-Endorphin-induced locomotor stimulation and reinforcement are associated with an increase in dopamine release in the nucleus accumbens. Psychopharmacology (Berlin) 104, 51-56.
59. Steiner, R. A., Kabigting, E., Lent, K. and Clifton, D. K. (1994) Diurnal rhythm in proopiomelanocortin mRNA in the arcuate nucleus of the male rat. Journal of Neuroendocrinology 6, 603-608.
60. Sutherland, G., Stapleton, J. A., Russell, M. A. H. and Feyerabend, C. (1995) Naltrexone, smoking behaviour and cigarette withdrawal. Psychopharmacology 120, 418-425.
61. Tobin, M. J., Jenouri, G. and Sackner, M. A. (1982) Effect of naloxone on change in breathing pattern with smoking. A hypothesis on the addictive nature of cigarette smoking. Chest 5, 530-537.
62. Tong, Y. and Pelletier, G. (1992) Role of dopamine in the regulation of proopiomelanocortin (POMC) mRNA levels in the arcuate nucleus and pituitary gland of the female rat as studied by in situ hybridization. Molecular Brain Research 15, 27-32.
63. Ward, S. J., Portoghese, P. S. and Takemori, A. E. (1982) Pharmacological characterization in vivo of the novel opiate, β-funaltrexamine. Journal of Pharmacology and Experimental Therapy 220, 494-498.
64. Weidenfeld, J., Bodoff, M., Saphier, D. and Brenner, T. (1989) Further studies on the stimulatory action of nicotine on adrenocortical function in the rat. Neuroendocrinology 50, 132-138.
65. Wilkinson, C. W., Shinsako, J. and Dallman, M. S. (1979) Daily rhythms in adrenal responsiveness to adrenocorticotropin are determined primarily by the time of feeding in the rat. Endocrinology 104, 350-359.
66. Wilkinson, L. (1988) SYSTAT: The System for Statistics. SYSTAT, Evanston, IL.
67. Winternitz, W. W. and Quillen, D. (1977) Acute hormonal response to cigarette smoking. Journal of Clinical Pharmacology 17, 389-397.
68. Wise, P. M., Scarbrough, K., Weiland, N. G. and Larson, G. H. (1990) Diurnal pattern of proopiomelanocortin gene expression in the arcuate nucleus of proestrous, ovariectomized, and steroid-treated rats: a possible role in cyclic luteinizing hormone secretion. Molecular Endocrinology 4, 886-892.
69. Young, W. S. and Zoeller, R. T. (1987) Neuroendocrine gene expression in the hypothalamus: in situ hybridization histochemical studies. Cellular and Molecular Neurobiology 7, 353-366.